Coronavirus (COVID-19) - Latest Information for Patients and Visitors

(La más reciente información para pacientes y visitantes)

 

Read Now (Lea ahora)
800-TEMPLE-MED Schedule Appointment
SEARCH TEMPLE HEALTH

A Study of Baricitinib (LY3009104) in Participants With COVID-19 (COV-BARRIER)

view all Clinical Trials

Overview

The reason for this study is to see if the study drug baricitinib is effective in hospitalized participants with COVID-19.

Contact

For more information about this trial or to inquire about eligibility, email breathe@tuhs.temple.edu or call 215-707-1359.